Craft

Advanced
BioXXmed

BioXXmed

Stock Price

€1.9

2024-10-10

Market Capitalization

€138.7 K

2024-10-10

Revenue

€3 K

FY, 2024

BioXXmed Summary

Company Summary

Overview
BioXXmed (formerly known as CytoTools) is a biotechnology company engaged in biomedicine investments. It offers financing for biomedical projects and investment portfolio management solutions.
Type
Public
Status
Active
HQ
Darmstadt, DE | view all locations
Website
https://bioxxmed.ag/en/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Mark-Andre Freyberg, Chief Executive Officer

    • Dirk Kaiser, Chief Research Officer

      • Marc Herwick, Chief Financial Officer

        LocationsView all

        1 location detected

        • Darmstadt, Hessen HQ

          Germany

          126 Klappacher Str.

        BioXXmed Financials

        Summary Financials

        Revenue (H1, 2025)
        €17.0K
        Gross profit (H1, 2025)
        €21.0K
        Net income (H1, 2025)
        (€256.0K)
        Cash (H1, 2025)
        €77.0K
        EBIT (H1, 2025)
        (€160.0K)
        Enterprise value
        $196.7K

        Competitors and Similar Companies

        Compare competitors

        Footer menu

        Product

        Solutions

        Resources

        Company

        © Craft.co 2026
        Share price data provided by IEX